<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201016049039N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-03-04</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>the effect of dry needling on walking in subjects with short leg muscles</public_title>
      <acronym></acronym>
      <scientific_title>The effect of dry needling on biomechanical data in subjects with hamstring tightness in dynamic tasks</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-10-24</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>16</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/51724</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients are randomly divided into two groups of dry needle and sham needle by block-balance method from randomization site, in such a way that we give the site software the number of groups and the required number of samples, then the site a category According to the number of samples we need, for example, the first person is in group a and the second person is in group b, and we write this category on paper and put the sum of the papers in a box and each sample Considering that he is the second person in the group, he takes his paper and gives it to us. In this method, the number of groups, the maximum number of people considered according to the list provided by the site are randomly placed in groups, Blinding description: We write the category received from the site on a piece of paper and fold the paper and put all the papers in a box, and each sample, given that it is the second person in the group, takes its paper and gives it to us, and this is the content of the group. The layout inside the paper is unaware.</study_design>
      <phase>N/A</phase>
      <hc_freetext>hamstring muscles tightness.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Dry needle group, in this group, the patient lies prone and in three points behind each thigh, which is the motor point of the hamstring muscles, a 50 * 30 mm echo needle made in China is inserted and a needle in the opposite direction is inserted too. Rotate the clock 360 degrees for 15 seconds and then the needle is inserted into the tissue for 20 minutes. We perform this intervention within 5 days with an interval of 48 hours. Intervention 2: Control group: In this group which is called the sham-needle group, the patient lies prone and in three points behind each thigh, which is the motor point of the hamstring muscles, researcher inserts a 13 * 20 mm echo needle made in China and then inserts the needle in the tissue for 20 minutes. And do this within 5 days with an interval of 48 hours.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Data on study variables

When:
march 2020

To whom:
researchers

Conditions:
In case of related study

Where to obtain:
parisa fakhari

How to obtain:
By sending an email and submitting a request to receive data

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Parisa Fakhari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 185, East 405, Beigi Alley, Golha Blvd, Phase Four of Mehrshahr</address>
        <city>Karaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3183864887</zip>
        <telephone>+98 26 3350 7991</telephone>
        <email>p_fakhari@razi.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Parisa Fakhari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 185, East 405, Beigi Ave, Golha Blvd, Phase Four Of Mehrshahr</address>
        <city>Karaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3183864887</zip>
        <telephone>+98 26 3350 7991</telephone>
        <email>p_fakhari@razi.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Extension limit in active knee extension test equal or greater than 20 degrees
Age range 18-40 years
Body mass index 18.5-29.9
Normal Q-angle between 16-18
Negative navicular drop test</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Fear of needling
Metabolic disorders such as diabetes
Pregnancy
Severe genovarum and genovalgom
Athlete
Coagulation problems
Neurological problems such as epilepsy
Withdrawal from cooperation
Failure to complete assessment tests
Failure to complete treatment sessions
Feeling pain or discomfort during assessment and treatment
Receive secondary treatment during treatment sessions
Dissatisfaction with continued treatment</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Dry needle group, in this group, the patient lies prone and in three points behind each thigh, which is the motor point of the hamstring muscles, a 50 * 30 mm echo needle made in China is inserted and a needle in the opposite direction is inserted too. Rotate the clock 360 degrees for 15 seconds and then the needle is inserted into the tissue for 20 minutes. We perform this intervention within 5 days with an interval of 48 hours.</i_keyword>
      <i_keyword>Control group: In this group which is called the sham-needle group, the patient lies prone and in three points behind each thigh, which is the motor point of the hamstring muscles, researcher inserts a 13 * 20 mm echo needle made in China and then inserts the needle in the tissue for 20 minutes. And do this within 5 days with an interval of 48 hours.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Popliteal angle. Timepoint: Before the intervention, immediately after the intervention of the first session, after the intervention of the third session, after the intervention of the fifth session. Method of measurement: goniometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The mean displacement of center of pressure. Timepoint: Before the intervention, immediately after the intervention, after the third session, after the fifth session. Method of measurement: By Moticon smart insole.</sec_outcome>
      <sec_outcome>Velocity of center of pressure displacement. Timepoint: Before the intervention, immediately after the intervention, after the third session, after the fifth session. Method of measurement: By Moticon smart insole.</sec_outcome>
      <sec_outcome>Ground reaction force. Timepoint: Before the intervention, immediately after the intervention, after the third session, after the fifth session. Method of measurement: By Moticon smart insole.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-10-28</approval_date>
        <contact_name>Ethics Committee in Research School of Medicine - Tehran University of Medical Sciences</contact_name>
        <contact_address>No185, East 405, Beigi Ave, Golha Blvd, 4th Phase of Mehrshahr Karaj Alborz Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
